Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 7, 2000, Pages 673-683

  Laserson, K F ^a,b   Osorio, L ^c   Sheppard, J D ^d   Hernandez H ^c   Benitez A M ^c   Brim, S ^d   Woodley, C L ^d   Hazbon M H ^c   Villegas, M V ^c   Castano M C ^e   Henriquez, N ^f   Rodriguez, E ^a   Metchock, B ^d   Binkin, N J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e Secretaria Departamental Salud Valle   (Colombia)

^f Secretaria Salud Munic Buenaventura   (Colombia)

Author keywords

Beijing family; Colombia; DNA fingerprinting; Multidrug resistance; RFLP; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COLOMBIA; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; COLOMBIA; DISEASE OUTBREAKS; DNA FINGERPRINTING; HUMANS; MEDICAL ERRORS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGRAM EVALUATION; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 12944270498     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization. Global tuberculosis control: WHO Report 1999. WHO/CDC/CPC/TB/99.259. Geneva: World Health Organization, 1999.
2. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance 1994-1997. N Engl J Med 1998; 338: 1641-1649.
3. Mahmoudi A, Iseman M D. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68.
4. Byrd R B, Horn B R, Solomon D A, Griggs G A, Wilder N J. Treatment of tuberculosis by the nonpulmonary physician. Ann Inter Med 1977; 86: 799-802.
5. Sumartojo E M, Geiter L J, Miller B, Hale B E. Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health 1997; 87: 2008-2011.
6. Daley C L, Small P M, Schecter G F, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-235.
7. Edlin B R, Tokars J I, Grieco M H, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
8. Coronado V G, Beck-Saguë C M, Hutton M D, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993; 168: 1052-1055.
9. Small P, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
10. Ministry of Health, Republic of Colombia. Guide to integrated care: prevention and control of tuberculosis [Spanish]. Bogota, Colombia: Ministry of Health, 1997.
11. Departamento Nacional de Estadistica (DANE). Informe anual de estadística (Annual Statistical Report). Bogotá, Colombia: National Department of Statistics Administration, 1993.
12. Kent P T, Kubica G. Public health mycobacteriology: a guide for the level III laboratory. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1985: 166-174.
13. Van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
14. Plikaytis B B, Marden J L, Crawford J T, Woodley C L, Butler W R, Shinnick T M. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol 1994; 32: 1542-1546.
15. Van Soolingen D, Qian L, Dehaas P E W, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33: 3234-3238.
16. Bifani P J, Plikaytis B B, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275: 52-457.
17. Kurepina N E, Sreevatsan S, Plikaytis B B, et al. Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. Tubercle Lung Dis 1998; 79: 31-42.
18. Enarson D A, Rieder H L, Arnadottir T. Tuberculosis guide for low income countries 3rd ed. Paris: IUATLD, 1994.
19. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
20. Salomon N, Perlman D C, DePalo V A, Kolokathis A, Wilets I. Drug-resistant tuberculosis: factors associated with rise in resistance in an HIV-infected urban population. Mt Sinai J Med 1994; 61: 341-348.
21. Riley L W, Arathoon E, Loverde V D. The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infections: a community-based study. Am Rev Respir Dis 1989; 139: 1282-1285.
22. Salomon N, Perlman D C, Friedman P, Buchstein S, Kreisworth B N, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1245-1252.
23. Burman W J, Reves R R, Hawkes A P, et al. DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997; 155: 1140-1146.
24. Braden C R, Templeton G L, Cave M D, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175: 1446-1452.
25. Reporte Anual de la Sociedad Portuaria de Buenaventura (Annual Report of the Port Society of Buenaventura). Buenaventura, Colombia: Port Society of Buenaventura Ltd., 1999.